Myrifa 200mg Tablet
By Myrifa
Rx
10 Tablet in a Strip

Composition
Rifaximin(200mg)

Manufacturer - Biophar Lifesciences Pvt Ltd
Elante Office,Industrial&Buisness Park, Phase-I,Chandigarh(UT)-160002, Registered Office : #34,Raipur Kalan, Chandigarh - 160102

Expires on or after
October, 2025

liver
When using Myrifa 200mg Tablet, it is important to exercise caution if you have severe liver disease. Patients with such conditions may require a dose adjustment for this medication. It is advisable to consult your doctor for guidance on the appropriate use of Myrifa 200mg Tablet to ensure your liver health is taken into consideration.

kidney
Myrifa 200mg Tablet is considered safe for use in patients with kidney disease. Information indicates that dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Myrifa 200mg Tablet.

driving
Myrifa 200mg Tablet typically does not impact your driving ability.

pregnancy
Myrifa 200mg Tablet may not be safe to use during pregnancy as limited human studies and animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Myrifa 200mg Tablet is likely safe to use while breastfeeding. The limited human data available indicates that there is no significant risk to the baby.
Habit Forming | No |
Chemical Class | Rifamycin derivatives |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | RNA polymerase inhibitors- Rifamycins |
₹200
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024